Sandoz Group AG (D8Y) Opens High-Volume Biosimilar Facility in Slovenia

Sandoz opened a high-tech, high-volume biosimilar drug substance manufacturing center in Lendava, Slovenia, expanding in-house capacity and flexibility across its European network.Material DetailsContext by AI AnalystThis is an execution update on Sandoz’s ongoing capacity build-out for biosimilars…